Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd. (“Humanwell PuraCap”), founded in 2009 at the center of Wuhan Optics Valley – Humanwell Medical Industrial Park of Wuhan Biological Industry Base, covering an area of 60,253.54 square meters, is jointly established by Humanwell Healthcare and INSPIRE with an investment of RMB 1 billion.
Equipped with most advanced softgel manufacturing and packaging equipment from US, Europe, and South Korea, it is a world-class softgel pharmaceutical manufacturing base in China. Passing through the on-site audit of FDA with no defects in 2015 and 2017 respectively, it is the first softgel pharmaceutical manufacturing company approved by FDA in Hubei Province.
Humanwell PuraCap currently has a number of softgel production lines with annual capacity up to 8 billion softgels. Being able to provide highly quality softgel R&D, OEM service and China-US registration work, it is currently a supplier of major mainstream pharmaceutical retail enterprises in the US, and also cooperates with world-class pharmaceutical enterprises at home and abroad to provide OEM and product cooperation, etc.
Humanwell PuraCap is a pharmaceutical enterprise based on the high-end technology platform of the pharmaceutical industry in the world, which requires itself with strict international quality standards. It is a world-class pharmaceutical enterprise that can stand shoulder to shoulder with excellent global pharmaceutical enterprises.